ZBH · 8-K · 20260805PR333761
Operating Expense Trends
ZIMMER BIOMET HOLDINGS, INC. · 2026-08-05 · Importance 47 · Surprise 22
Second-quarter selling, general and administrative expense increased 10.4% to $899.3 million from $814.8 million. First-half SG&A increased 11.2% to $1,749.3 million from $1,573.5 million, exceeding the materiality threshold and contributing to operating-expense growth. Research and development expense declined to $104.8 million from $113.3 million in the second quarter and to $208.2 million from $223.9 million in the first half.